Tuesday, August 4, 2026

Korean Government Faces Backlash: U.S. Report Claims Discrimination Against American Companies

Lee Jun-seok criticizes a U.S. report alleging South Korea's discrimination against American firms, urging a strong government response.

North Korea Unveils Largest Greenhouse Farm: A 2026 Agricultural Revolution

North Korea inaugurates the Sinuiju Greenhouse Complex, a monumental project aimed at transforming agriculture and improving local living conditions.

Sam Chun Dang Pharm Soars to Daily Limit After Securing U.S. FDA Response

Sam Chun Dang Pharm's stock surged after FDA's Pre-ANDA response for its generic oral semaglutide, marking a key milestone for market entry.

Tag: MetaVia

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.